Concerning BRAF mutation in thyroid cancer, two reports have demonstrated that BRAF mutation promotes NHEJ activity through upregulation of NHEJ1 and it is also associated with radioresistance (Robb et al., 2018, 2019). This evidence concerns the gene NHEJ1 and thyroid gland carcinoma.